Welcome to the first-ever For the Win guide for the Pro Volleyball Federation (PVF). On January 9, PFV begins its second ...

The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...

Pfizer (PFE) closed the most recent trading day at $26.91, moving -0.83% from the previous trading session. This change lagged the S&P 500's 0.16% gain on the day. Meanwhile, the Dow experienced a ...

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced an expansion of their partnership with ...

Lumotive, a pioneer in optical semiconductor technology, today announced the integration of its groundbreaking MD41 Development Kit with Sony Semiconductor Solutions' IMX459 and ...

Pfizer Inc. closed $4.65 short of its 52-week high ($31.54), which the company reached on July 30th.

The stock's fall snapped a two-day winning streak.

Mexico's tax authority SAT issued new tariffs on Tuesday, which it said will strengthen the surveillance of goods from Asia, ...

"Federal law requires defendants to ensure that their drug labels remain accurate, and when new scientific information ...

Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options ...